2026
Quarterly rpt on consolidated results for the financial period ended 31 Dec 2025
NOVA MSC BERHAD 27 February 2026 Financial Year End 30 Jun 2025 Quarter 2 Qtr Quarterly report for the financial period ended 31 Dec 2025 The figures have not been audited NMSC_report_FY2526_2Qtr_final.pdf
Changes in Sub. S-hldr’s Int (Section 138 of CA 2016) – MR OOI KENG THYE
NOVA MSC BERHAD 26 January 2026 Particulars of substantial Securities Holder Name MR OOI KENG THYE Nationality/Country of incorporation Malaysia Descriptions (Class) Ordinary shares Details of changes No Date of change No of securities Type of Transaction Nature of Interest 1 22 Jan 2026 320,000 Acquired Direct Interest Name of registered holder Ooi Keng Thye Description of “Others” Type…
Changes in Sub. S-hldr’s Int (Section 138 of CA 2016) – MR OOI KENG THYE
NOVA MSC BERHAD 22 January 2026 Particulars of substantial Securities Holder Name MR OOI KENG THYE Nationality/Country of incorporation Malaysia Descriptions (Class) Ordinary shares Details of changes No Date of change No of securities Type of Transaction Nature of Interest 1 20 Jan 2026 2,323,400 Acquired Direct Interest Name of registered holder Ooi Keng Thye Description of “Others” Type…
Changes in Sub. S-hldr’s Int (Section 138 of CA 2016) – MR OOI KENG THYE
NOVA MSC BERHAD 20 January 2026 Particulars of substantial Securities Holder Name MR OOI KENG THYE Nationality/Country of incorporation Malaysia Descriptions (Class) Ordinary shares Details of changes No Date of change No of securities Type of Transaction Nature of Interest 1 16 Jan 2026 500,000 Acquired Direct Interest Name of registered holder Ooi Keng Thye Description of “Others” Type…
Changes in Sub. S-hldr’s Int (Section 138 of CA 2016) – MR OOI KENG THYE
NOVA MSC BERHAD 12 January 2026 Particulars of substantial Securities Holder Name MR OOI KENG THYE Nationality/Country of incorporation Malaysia Descriptions (Class) Ordinary shares Details of changes No Date of change No of securities Type of Transaction Nature of Interest 1 08 Jan 2026 1,000,000 Acquired Direct Interest Name of registered holder Ooi Keng Thye Description of “Others” Type of…
CO-FOUNDERS OF EyRIS RECOGNISED AMONG THE WORLD’S TOP OPHTHALMOLOGY SCHOLARS
5 Jan 2026 – EyRIS is proud to announce that our co-founders, Associate Professor Daniel Ting Director of SingHealth AI Office and Head of AI and Digital Innovation in Singapore Eye Research Institute (SERI) , and Professor Wong Tien Yin Senior Vice-Chancellor of Tsinghua Medicine and Vice-Provost of Tsinghua University, China have been recognised by ScholarGPS as the 2nd &…